By_IN assaying_VBG CAT_NN enzyme_NN activity_NN across_IN a_DT 24-h_JJ PRL_NN induction_NN time_NN course_NN ,_, we_PRP were_VBD able_JJ to_TO assign_VB G1_NN vs._CC S_NN phase_NN PRL_NN responses_NNS of_IN the_DT IRF-1_NN gene_NN to_TO different_JJ regions_NNS of_IN the_DT IRF-1_NN and_CC promoter_NN DNA_NN ._.
A_DT number_NN of_IN genes_NNS known_VBN to_TO be_VB induced_VBN following_VBG T_NN cell_NN activation_NN and_CC associated_VBN with_IN cell_NN growth_NN were_VBD increased_VBN in_IN the_DT transfectants_NNS ,_, including_VBG c-fos_NN ,_, c-myc_NN ,_, c-myb_NN ,_, HLA-DR_NN ,_, lck_NN ,_, NF-kappa_NN B_NN ,_, interleukin-2_NN and_CC interleukin-2_NN receptor_NN alpha_NN IL-2R_NN alpha_NN ._.
Furthermore_RB ,_, p65_NN was_VBD detected_VBN in_IN the_DT nuclei_NNS of_IN some_DT lymphocytes_NNS ._.
The_DT lytic_JJ cycle_NN of_IN EBV_NN infection_NN was_VBD induced_VBN by_IN transfection_NN of_IN the_DT cells_NNS with_IN the_DT coding_NN region_NN of_IN the_DT P3HR-1_NN defective_JJ genome_NN ._.
Nuclear_JJ factor-kappa_NN B_NN NF-kappa_NN B_NN is_VBZ a_DT transcription_NN factor_NN that_WDT binds_VBZ to_TO the_DT consensus_NN DNA_NN sequence_NN in_IN the_DT cis-acting_JJ elements_NNS of_IN various_JJ genes_NNS ._.
In_IN contrast_NN ,_, Egr-1_NN expression_NN is_VBZ abrogated_VBN in_IN group_NN I_NN Burkitt_NN tumor_NN cells_NNS ,_, irrespective_JJ of_IN the_DT EBV_NN genome_NN carrying_NN status_NN ._.
Some_DT criteria_NNS which_WDT can_MD be_VB used_VBN to_TO define_VB steroid-resistant_JJ bronchial_JJ asthma_NN are_VBP listed_VBN here_RB ._.
Constitutive_JJ expression_NN of_IN IFN-alpha5_NN and_CC IFN-beta_NN was_VBD detected_VBN in_IN different_JJ lymphoid_JJ cells_NNS including_VBG peripheral_JJ blood_NN mononuclear_JJ cells_NNS from_IN normal_JJ individuals_NNS following_VBG amplification_NN of_IN IFN_NN mRNA_NN by_IN reverse_JJ transcriptase-polymerase_NN chain_NN reaction_NN and_CC direct_JJ sequencing_NN of_IN the_DT amplified_VBN product_NN ._.
Specific_JJ mRNAs_NNS for_IN c-fos_NN and_CC c-jun_NN were_VBD detectable_JJ within_IN 30_CD min_NN after_IN cell_NN activation_NN and_CC reached_VBD maximal_JJ levels_NNS within_IN 2_CD h_NN ._.
An_DT acquired_JJ form_NN of_IN peripheral_JJ resistance_NN to_TO glucocorticoids_NNS was_VBD suspected_VBN ._.
Sequencing_NN of_IN the_DT GR_NN cDNA_NN and_CC gene_NN including_VBG the_DT 2.3-kb_JJ coding_NN region_NN ,_, the_DT junctions_NNS ,_, the_DT known_JJ region_NN ,_, and_CC approximately_RB 300_CD bp_NN of_IN the_DT revealed_VBD no_DT alterations_NNS ._.
However_RB ,_, the_DT reduced_VBN expression_NN of_IN these_DT proteins_NNS was_VBD not_RB the_DT result_NN of_IN a_DT global_JJ defect_NN because_IN CD3_NN cross-linking_NN induced_VBD an_DT equivalent_JJ increase_NN in_IN intracellular-free_JJ calcium_NN ions_NNS ,_, as_RB well_RB as_IN NFATp_NN dephosphorylation_NN ,_, translocation_NN to_TO the_DT nucleus_NN ,_, and_CC DNA_NN binding_NN in_IN both_CC normal_JJ and_CC anergic_JJ T_NN cells_NNS ._.
Erbstatin_NN and_CC genistein_NN inhibited_VBD the_DT sIg-crosslinking-induced_JJ Egr-1_NN mRNA_NN expression_NN in_IN a_DT dose-dependent_JJ manner_NN parallel_JJ to_TO that_WDT observed_VBN in_IN the_DT inhibition_NN of_IN sIg-crosslinking-induced_JJ protein_NN tyrosine_NN phosphorylation_NN ._.
This_DT lack_NN of_IN sensitivity_NN is_VBZ unexplained_JJ but_CC is_VBZ not_RB attributable_JJ to_TO abnormalities_NNS of_IN cellular_JJ glucocorticoid_NN receptors_NNS ._.
In_IN particular_JJ ,_, Tax_NN is_VBZ capable_JJ of_IN modulating_VBG the_DT expression_NN or_CC activity_NN of_IN various_JJ host_NN transcription_NN factors_NNS ,_, including_VBG members_NNS of_IN the_DT NF-kappa_NN and_CC families_NNS ,_, as_RB well_RB as_IN the_DT cellular_JJ factors_NNS HEB-1_NN and_CC p67SRF_NN ._.
Transient_JJ overexpression_NN of_IN Bcl-2_NN in_IN mouse_NN and_CC human_JJ T_NN cell_NN blasts_NNS did_VBD not_RB block_VB Fas-mediated_JJ apoptosis_NN ,_, whereas_IN etoposide-_NN and_CC glucocorticoid-induced_JJ cytotoxicity_NN was_VBD potently_RB inhibited_VBN ._.
These_DT results_NNS confirm_VBP and_CC extend_VBP the_DT notion_NN of_IN the_DT functional_JJ conservation_NN of_IN the_DT AIR-1_JJ gene_NN product_NN across_IN species_NNS barriers_NNS ._.
This_DT synergistic_JJ suppression_NN could_MD not_RB be_VB explained_VBN by_IN an_DT increase_NN in_IN cAMP_NN accumulation_NN in_IN T_NN cells_NNS stimulated_VBN with_IN DEX_NN and_CC PGE2_NN ._.
Two_CD pp56-LRB-lck-RRB-_NN mutants_NNS lacking_VBG either_CC the_DT entire_JJ catalytic_JJ domain_NN or_CC the_DT entire_JJ NH2_NN regulatory_JJ domain_NN were_VBD generated_VBN ,_, and_CC abilities_NNS to_TO trigger_VB transactivation_NN of_IN the_DT TCR-regulated_JJ nuclear_JJ factor_NN of_IN activated_VBN T_NN cells_NNS NF-AT_NN region_NN of_IN the_DT IL-2_NN promoter_NN were_VBD compared_VBN ._.
It_PRP is_VBZ interesting_JJ that_IN in_IN humans_NNS and_CC rats_NNS ,_, cortical_JJ thymocytes_NNS undergoing_VBG negative_JJ selection_NN can_MD still_RB induce_VB IL-2R_NN alpha_NN expression_NN and_CC even_RB be_VB rescued_VBN in_FW vitro_FW ,_, if_IN exogenous_JJ IL-2_NN is_VBZ provided_VBN ._.
Thus_RB the_DT inhibitory_JJ effect_NN of_IN insulin_NN on_IN the_DT GR_NN binding_NN power_NN is_VBZ both_CC dose-_NN and_CC time-dependent_JJ ,_, which_WDT strongly_RB suggests_VBZ that_IN GR_NN is_VBZ tonically_RB controlled_VBN by_IN insulin_NN concentration_NN change_NN under_IN physiological_JJ conditions_NNS ._.
We_PRP show_VBP that_IN a_DT cellular_JJ reducing_NN catalyst_NN thioredoxin_NN Trx_NN plays_VBZ a_DT major_JJ role_NN in_IN activation_NN of_IN the_DT DNA_NN binding_NN of_IN NF_NN kappa_NN B_NN in_FW vitro_FW and_CC stimulation_NN of_IN transcription_NN from_IN the_DT NF_NN kappa_NN B-dependent_JJ gene_NN expression_NN ._.
G0S24_NN has_VBZ potential_JJ sites_NNS for_IN transcription_NN factors_NNS in_IN the_DT flank_NN and_CC intron_NN ;_: these_DT include_VBP a_DT serum_NN response_NN element_NN ._.
Although_IN inhibition_NN of_IN IL-4-driven_JJ germline_NN C_NN epsilon_NN transcription_NN by_IN NAC_NN was_VBD not_RB sufficient_JJ ,_, the_DT agent_NN remarkably_RB diminished_VBD anti-CD40_JJ mAb-mediated_JJ up-regulation_NN of_IN germline_NN C_NN epsilon_NN transcription_NN ._.
Further_JJ evidence_NN suggests_VBZ that_IN Nef_NN inhibits_VBZ NF-kappa_NN B_NN induction_NN by_IN interfering_VBG with_IN a_DT signal_NN derived_VBN from_IN the_DT T-cell_NN receptor_NN complex_NN ._.
